Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record for the Phase I durvalumab and tremelimumab study in recurrent or metastatic head and neck cancer is displayed, including its study design, eligibility criteria, outcomes, and locations.
    Difference
    54%
    Check dated 2026-11-08T04:32:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:31:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice appears at the top of the page announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:32:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T01:07:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:44:02.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Users now see a 403 Forbidden error on the study page, replacing the normal study record content and navigation. The page is currently inaccessible, preventing viewing details for this trial.
    Difference
    0.5%
    Check dated 2026-09-27T01:27:09.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.